These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6631217)

  • 1. Metabolic heterogeneity of post-lipolysis rat mesenteric lymph small chylomicrons produced in vitro.
    Chajek-Shaul T; Eisenberg S; Oschry Y; Olivecrona T
    J Lipid Res; 1983 Jul; 24(7):831-40. PubMed ID: 6631217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer of human lymph chylomicron constituents to other lipoprotein density fractions during in vitro lipolysis.
    Schaefer EJ; Wetzel MG; Bengtsson G; Scow RO; Brewer HB; Olivecrona T
    J Lipid Res; 1982 Dec; 23(9):1259-73. PubMed ID: 7161556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic fate of chylomicron phospholipids and apoproteins in the rat.
    Tall AR; Green PH; Glickman RM; Riley JW
    J Clin Invest; 1979 Oct; 64(4):977-89. PubMed ID: 225354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein metabolism in the suckling rat: characterization of plasma and lymphatic lipoproteins.
    Fernando-Warnakulasuriya GJ; Eckerson ML; Clark WA; Wells MA
    J Lipid Res; 1983 Dec; 24(12):1626-38. PubMed ID: 6686845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat.
    Mjos OD; Faergeman O; Hamilton RL; Havel RJ
    J Clin Invest; 1975 Sep; 56(3):603-15. PubMed ID: 169294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Composition, removal and metabolic fate of chylomicrons derived from diabetic rats.
    Levy E; Shafrir E; Ziv E; Bar-On H
    Biochim Biophys Acta; 1985 May; 834(3):376-85. PubMed ID: 3995073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of a very low density lipoprotein subpopulation from familial dysbetalipoproteinemia to in vitro lipolytic conversion to the low density lipoprotein density fraction.
    Chung BH; Segrest JP
    J Lipid Res; 1983 Sep; 24(9):1148-59. PubMed ID: 6631244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
    Murdoch SJ; Breckenridge WC
    Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesteryl esters in lymph chylomicrons: contribution from high density lipoprotein transferred from plasma into intestinal lymph.
    Oliveira HC; Nilausen K; Meinertz H; Quintão EC
    J Lipid Res; 1993 Oct; 34(10):1729-36. PubMed ID: 8245723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein lipase enhances removal of chylomicrons and chylomicron remnants by the perfused rat liver.
    Skottova N; Savonen R; Lookene A; Hultin M; Olivecrona G
    J Lipid Res; 1995 Jun; 36(6):1334-44. PubMed ID: 7666010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein and lipid distribution between vesicles and HDL-like particles formed during lipolysis of human very low density lipoproteins by perfused rat heart.
    Tam SP; Breckenridge WC
    J Lipid Res; 1983 Oct; 24(10):1343-57. PubMed ID: 6644185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental nephrotic syndrome: removal and tissue distribution of chylomicrons and very-low-density lipoproteins of normal and nephrotic origin.
    Levy E; Ziv E; Bar-On H; Shafrir E
    Biochim Biophys Acta; 1990 Apr; 1043(3):259-66. PubMed ID: 2322571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase.
    Xiang SQ; Cianflone K; Kalant D; Sniderman AD
    J Lipid Res; 1999 Sep; 40(9):1655-63. PubMed ID: 10484612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of chylomicron and VLDL remnants to post-heparin lipolysis in ApoE-deficient mice: the role of apoE in lipoprotein lipase-mediated lipolysis in vivo and in vitro.
    Zsigmond E; Fuke Y; Li L; Kobayashi K; Chan L
    J Lipid Res; 1998 Sep; 39(9):1852-61. PubMed ID: 9741698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoprotein composition and turnover in rat intestinal lymph during steady-state triglyceride absorption.
    Holt PR; Wu AL; Clark SB
    J Lipid Res; 1979 May; 20(4):494-502. PubMed ID: 222857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma clearance of chylomicrons from butterfat is not dependent on saturation: studies with butterfat fractions and other fats containing triacylglycerols with low or high melting points.
    Phan CT; Mortimer BC; Martins IJ; Redgrave TG
    Am J Clin Nutr; 1999 Jun; 69(6):1151-61. PubMed ID: 10357733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the processing of chylomicron remnants and beta-VLDL by macrophages.
    Ellsworth JL; Fong LG; Kraemer FB; Cooper AD
    J Lipid Res; 1990 Aug; 31(8):1399-411. PubMed ID: 2280181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic uptake and processing of cholesterol and cholesteryl ester from chylomicron remnants: an in vivo study in the rat.
    Bravo E; Guldur T; Botham KM; Mayes PA; Cantafora A
    Biochim Biophys Acta; 1992 Jan; 1123(1):85-91. PubMed ID: 1730049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fate of apolipoproteins C-1, C-iii, and E during lipolysis of human very low density lipoproteins in vitro.
    Tam SP; Dory L; Rubinstein D
    J Lipid Res; 1981 May; 22(4):641-51. PubMed ID: 7276737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of high density lipoproteins in regulation of hepatic fatty acid synthesis by chylomicron and very low density lipoprotein remnants.
    Lakshmanan MR; Maten MV; Muesing RA; O'Looney P; Vahouny GV
    J Biol Chem; 1983 Apr; 258(8):4746-9. PubMed ID: 6833273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.